VEOZAH
NDC 0469-2460, fezolinetant, tablet, film coated, from Astellas Pharma US, Inc..
- Product NDC
- 0469-2460
- Status
- Listed
- Labeler
- Astellas Pharma US, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216578
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0469-2460 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEZOLINETANT45 mg/1
Pharmacologic classes
Neurokinin 3 Receptor Antagonist [EPC]; Neurokinin 3 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0469-2460-28 | 00469246028 | 4 CARTON in 1 TRAY (0469-2460-28) / 1 BOTTLE in 1 CARTON (0469-2460-07) / 7 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cae9f798-24f9-4580-a4fc-e6c710cbda3c
Use it
Look up 0469-2460 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0469-2460 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0469-2460. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.